Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding | 1.13% | $159.39M | $539.78B | 87.16% | 81 Outperform | |
| Roche Holding AG | 1.00% | $140.69M | CHF287.83B | 46.49% | 73 Outperform | |
| HSBC Holdings | 0.80% | $112.57M | $290.53B | 54.56% | 78 Outperform | |
| Shell | 0.77% | $108.59M | $221.77B | 17.34% | 78 Outperform | |
| Novartis | 0.69% | $96.66M | $309.51B | 54.70% | 80 Outperform | |
| Toyota Motor | 0.58% | $82.34M | $322.13B | 34.76% | 81 Outperform | |
| AstraZeneca | 0.57% | $80.34M | £234.40B | 29.12% | 80 Outperform | |
| SAFRAN SA | 0.53% | $74.67M | €136.93B | 34.31% | 67 Neutral | |
| Banco Bilbao | 0.49% | $68.47M | $129.22B | 79.97% | 76 Outperform | |
| TotalEnergies SE | 0.48% | $67.30M | €137.70B | 9.16% | 78 Outperform |